Back
Inhibrx Biosciences, Inc. Vs. NovaBay Pharmaceuticals, Inc. Industry Stock Comparison
Sell
44
INBX
Inhibrx Biosciences, Inc.
Last Price:
$76.07
Seasonality Move:
-8.44%
Buy
70
NBY
NovaBay Pharmaceuticals, Inc.
Last Price:
$5.72
Seasonality Move:
13.91%
Sell
44
Inhibrx Biosciences, Inc. (INBX)
is a Sell
Is Inhibrx Biosciences, Inc. a Buy, Sell or Hold?
-
The current Inhibrx Biosciences, Inc. [INBX] share price is $79.00. The Score for INBX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
INBX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
NovaBay Pharmaceuticals, Inc. (NBY)
is a Buy
Is NovaBay Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals, Inc. [NBY] share price is $5.64. The Score for NBY is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
-
NBY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
INBX Stock Price Chart
What is Inhibrx Biosciences, Inc.'s stock price today?
-
The Inhibrx Biosciences, Inc. share price today is $79.00The current trend is moderately bearish and INBX is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals, Inc.'s stock price today?
-
The NovaBay Pharmaceuticals, Inc. share price today is $5.64Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing slight selling pressure.
INBX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.62 | Buy |
| Relative Strength Index (14 RSI): | 48.22 | Sell |
| Chaikin Money Flow: | 95108 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (79.04 - 87.1) | Sell |
| Bollinger Bands (100): | (27.43 - 79.25) | Buy |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.11 | Buy |
| Relative Strength Index (14 RSI): | 71.51 | Buy |
| Chaikin Money Flow: | -26466 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.22 - 4.68) | Buy |
| Bollinger Bands (100): | (0.58 - 3.08) | Buy |
INBX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 81.07 | Sell |
| 20-day SMA: | 83.16 | Sell |
| 50-day SMA: | 77.38 | Buy |
| 200-day SMA: | 34.4 | Buy |
| 8-day EMA: | 80.28 | Sell |
| 20-day EMA: | 81.12 | Sell |
| 50-day EMA: | 73.58 | Buy |
| 200-day EMA: | 43.75 | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.2 | Buy |
| 20-day SMA: | 3.43 | Buy |
| 50-day SMA: | 2.03 | Buy |
| 200-day SMA: | 1.21 | Buy |
| 8-day EMA: | 5 | Buy |
| 20-day EMA: | 3.82 | Buy |
| 50-day EMA: | 2.49 | Buy |
| 200-day EMA: | 0.97 | Buy |
Inhibrx Biosciences, Inc. Earnings Growth & INBX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.52 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.25 per share, and an increase next year of $2.01 per share.
NovaBay Pharmaceuticals, Inc. Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and a decrease next year of $0.00 per share.
Inhibrx Biosciences, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||